In Vitro Susceptibilities of Isolates of Sporothrix schenckii to Itraconazole and Terbinafine
AUTOR(ES)
Kohler, Lidiane Meire
FONTE
American Society for Microbiology
RESUMO
Thirty isolates of the yeast form of Sporothrix schenckii were evaluated for in vitro susceptibility to itraconazole and terbinafine by the recommended NCCLS modified technique (M27-A2). The MICs of itraconazole obtained oscillated between 0.062 and 4.0 μg/ml, and those of terbinafine oscillated between 0.007 and 0.50 μg/ml; therefore, terbinafine showed greater in vitro activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=516298Documentos Relacionados
- Suscetibilidade in vitro de isolados de Sporothrix schenckii frente à terbinafina e itraconazol
- Avaliação da atividade in vivo e in vitro da terbinafina e itraconazol frente ao sporotrix schenckii
- In Vitro Susceptibility of Isolates of Aspergillus fumigatus and Sporothrix schenckii to Amphotericin B
- In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans
- In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
